1. Introduction {#sec1}
===============

Recent years have witnessed a rise in the number of people working late or night shifts in different employment sectors, such as healthcare, construction, transportation, and food preparation \[[@B1], [@B2]\]. The rate of shift work can exceed 15% of the workforce in many countries of North America, continental Europe, and Australia \[[@B2]\], and the trend is increasing. Night shift workers not only have higher short-term safety risks because of decreased alertness \[[@B3]\] but also have greater long-term health risks, including for diabetes \[[@B4]\], obesity \[[@B5]\], cardiovascular disease \[[@B6]\], depression \[[@B7]\], and cancer \[[@B8]\]. In 2007, a report by the International Agency for Research on Cancer (IARC) classified night shift work involving circadian disruption as "probably carcinogenic to humans" based on sufficient evidence in animal experiment and limited evidence in humans \[[@B9]\]. Therefore, investigating the influence of night shift work has captured attention. Most previous original studies verified the effect of night shift work on cancer risk, but the results are controversial for different cancers. Some findings have indicated that night shift work is significantly associated with higher cancer risk \[[@B10]--[@B39]\] whereas other studies have provided insignificant evidence for this relationship \[[@B40]--[@B66]\], motivating further study.

There were several postulated causal mechanisms that explain how night shift work multiplies cancer risk. First, melatonin, a marker of circadian rhythms, has a fundamental impact on inhibiting carcinogenesis through antioxidation, regulation of immunity, free radical scavenging, and antiangiogenesis \[[@B67]\]. Generally, night shift workers have a substantially decreased melatonin level during the nighttime \[[@B68], [@B69]\]. Melatonin suppression has been reported in breast \[[@B69]\], prostate \[[@B70]\], lung \[[@B71]\], ovarian \[[@B67]\], and gastrointestinal \[[@B72]\] cancers. Second, the 24-hour circadian rhythm is generated via interacting feedback loops of the circadian genes in all cells of both the hypothalamic suprachiasmatic nucleus (SCN) and all peripheral tissues \[[@B73], [@B74]\]. Night shift work can induce a conflict between the endogenous circadian clock and the external shifted sleep period and feeding behavior, leading to a dampening of the gene expression rhythm (25% of circadian genes) and subsequent disordered expression of transcription and translation in these cells \[[@B73], [@B74]\]. These disturbances can interfere with cell proliferation, apoptosis, hormonal balancing, metabolism, DNA damage repair, and immune and neuroendocrine functions. Recent studies have uncovered that the disruptive expression of circadian genes especially increases the risk of cancers in the immune, skeletal, digestive, and reproductive systems in which cell proliferation, metabolism, and DNA damage repair are required to maintain daily function \[[@B74]\]. Overall, the mechanisms based on hormonal and molecular levels manifest that the influence of night shift work on cancer is systemic and is not limited to a specific organ. However, many previous meta-analyses have identified the association of night shift work with only one type of cancer, including breast \[[@B75]--[@B78]\], prostate \[[@B79]--[@B81]\], and colorectal \[[@B82]\] cancers, among others. Only one study \[[@B8]\] analyzed the relationship between night shift work and the risk of cancers in women. Accordingly, we aimed to classify the association between night shift work and the risk of multiple cancers from a comprehensive perspective.

Previous studies have revealed that the circadian timing system differs in the sexes, which is mediated by different neuroendocrine contexts, such as sex hormones and their receptors in SCN \[[@B16], [@B83], [@B84]\]. Compared with male sex, female sex has been associated with earlier timing and larger amplitude of melatonin and earlier timing and longer duration of sleep \[[@B85], [@B86]\]. After night shift work, women showed greater impaired performance in health and cognition compared with men. For example, accuracy, alertness, the amplitude of melatonin, and working memory deteriorate more in women \[[@B3], [@B86], [@B87]\], enabling us to understand why female was more susceptible to sleep and wake disturbances after shift work \[[@B3]\]. More intense response to shift work in women reminds us whether the effect of night shift work on cancers varies with different genders.

Consequently, we conducted a meta-analysis to investigate this sex difference. We also expanded upon previous meta-analyses by not only evaluating the association between night shift work and a specific cancer but also estimating whether there was a dose--response relationship between night shift work and the risk of multiple cancers.

2. Methods {#sec2}
==========

2.1. Search Strategy {#sec2.1}
--------------------

We conducted a comprehensive updated search through May 2018 using PubMed, Embase, and Web of Science databases. Two investigators searched for eligible English articles independently. The search terms were "night shift work" or "rotating shift work" or "night work" or "shift work" and "carcinoma" or "neoplasm" or "tumor" or "cancer". In addition, we manually reviewed the reference lists of articles for additional relevant studies.

2.2. Inclusion and Exclusion Criteria {#sec2.2}
-------------------------------------

Studies were included if they satisfied the following criteria: (i) the research was a case-control study, cohort study, or nested case-control study; (ii) the exposure of interest was night shift work, and the outcome of interest was the risk of any type of cancer; (iii) the study reported adjusted risk estimates (odds ratio, OR; relative risk, RR; hazard ratio, HR) with 95% confidence intervals (CIs) or provided sufficient data to allow calculation. Studies were excluded if they satisfied the following criteria: (i) the study did not provide sufficient data; (ii) the study mentioned recurrent cancer; (iii) when more than one article was based on the same study population, we only included the study with the largest number of cases.

2.3. Data Extraction {#sec2.3}
--------------------

Data extraction was conducted independently by two authors for the following items: first author, publication year, study location, study design, number of cases, occupation, quality score, definition of exposure, participant sex, type of cancer, adjusted OR with 95% CI, adjusted covariates, and exposure assessment. As the prevalence of tumor is very low, we considered that ORs equaled RRs or HRs, providing similar risk estimates \[[@B88]\]. According to the definition of work schedule, we divided work schedules into rotating shift (working a regular shift schedule), fixed shift (permanent night work), and mixed (with no clear work schedule). ORs of the longest versus shortest exposure time were extracted from articles as the exposure indicator for statistical analysis. We also extracted dose information from ordinal categorical data (≥3 levels of the exposure category) for dose--response meta-analysis.

2.4. Quality Assessment {#sec2.4}
-----------------------

Two authors performed quality assessment using the Newcastle-Ottawa Quality Assessment Scale (NOS) \[[@B89]\]. The scale comprises a total of 9 points on the three parts of the NOS, including participant selection (0--4 points), comparability (0--2 points), and exposure or outcome assessment (0--3 points). Scores of ≥7 indicate a high quality.

2.5. Statistical Analysis {#sec2.5}
-------------------------

All statistical analyses were performed using Stata version 12.0 (StataCorp, College Station, TX, USA). We preferentially extracted adjusted ORs from original articles to evaluate the association between night shift work and cancer risk. If there were no adjusted ORs for specific subgroup analyses, a number of cases and participants would be extracted to calculate OR. The inverse variance method was used to combine ORs. If *I* ^2^ for the heterogeneity test was ≤50%, a fixed effects model was adopted to pool ORs; otherwise, a random effects model was selected. To explore potential heterogeneity, we performed subgroup analyses, metaregression analyses, and sensitivity analyses. One subgroup analysis was the classification of work schedules; we used a random effects model to evaluate the effect size for cancer on different work schedules \[[@B80]\]. To confirm the stability of results, a sensitivity analysis was conducted by omitting one study and then recalculating the rest of studies. The leave-one-out analysis was used to examine the weight of influence of each study on pooled OR \[[@B90]\].

A generalized least-squares trend (GLST) model was used to estimate the overall dose--response relationship of night shift work and the risk of cancer by computing risk estimates for different ordinal levels of night shift work. There were at least three ordinal levels of the exposure category in each study. The midpoint of the upper and lower boundaries of each level was considered the average exposure. The upper boundary of the highest level was considered the same as the adjacent category if it was not provided \[[@B76]\]. We used a two-stage random effect model to evaluate the linearity between night shift work and the risk of cancer.

Potential publication bias was estimated with the Begg funnel plot. Furthermore, the contour-enhanced funnel plot and the trim and fill method were used together to analyze the cause of bias. All reported *P* values were two-sided, and statistical significance was set at *P* ≤ 0.05.

3. Results {#sec3}
==========

3.1. Study Selection {#sec3.1}
--------------------

[Figure 1](#fig1){ref-type="fig"} illustrates the results of the literature search and the process of selection. A total of 753 articles were initially identified from PubMed, Embase, and Web of Science databases. After screening based on the title and abstract, 143 articles were selected for full-text assessment; 53 studies were eligible for the final analysis. We also retrieved four relevant articles from the reference lists. Finally, 57 studies \[[@B10]--[@B66]\] were included in the analysis of the association of night shift work with risk of cancer.

3.2. Study Characteristics {#sec3.2}
--------------------------

The characteristics of the abovementioned studies are summarized in [Table 1](#tab1){ref-type="table"}. Fifty-seven articles were included in this meta-analysis, including 21 case-control studies, 6 nested case-control studies, and 30 cohort studies. One article \[[@B10]\] included two cohorts, the Nurses\' Health Study (NHS) and Nurses\' Health Study II (NHS II). Therefore, a total of 58 studies were finally enrolled, involving 225,976 cases and 5,143,838 participants. We extracted information about sex in each article, except these articles that did not include classification by sex \[[@B12], [@B15], [@B48]\], to analyze the effect of night shift work on cancers in men and women separately. Several studies \[[@B20], [@B28], [@B43], [@B44], [@B53]\] analyzed the association between night shift work and different kinds of cancers. We also classified all kinds of cancer analyzed in the included studies into seven categories, including digestive system, hematological system, prostate, breast, reproductive system, lung, and skin cancers. A total 27 articles were from Europe, 11 from Asia, 17 from North America, and 3 from Australia. Most studies were based on a population with no specific occupation whereas other studies involved participants with a specific occupation, such as nurses, textile workers, women in the military, and pilots. According to the definition of night shift work, work schedules were classified as rotating shift (29 studies), fixed shift (9 studies), or mixed shift (27 studies). In fact, a cross section of studies described different work schedules, which we extracted simultaneously. Exposure assessment was performed using a questionnaire, interview, or databases. A total 43 studies were adjusted for more than four confounders and 15 studies for fewer than four confounders. The average NOS score was 7.2, and scores ranged from 4 to 8.

3.3. Association between Night Shift Work and the Risk of Various Cancers {#sec3.3}
-------------------------------------------------------------------------

The random effects model was used to pool the ORs, indicating the relationship between night shift work and risk of multiple cancers. The pooled OR was 1.15 (95% CI = 1.08--1.22, *P* \< 0.001), with high heterogeneity (*I* ^2^ = 76.2%, *P* ≤ 0.001) (shown in online [Figure S1](#supplementary-material-1){ref-type="supplementary-material"}). We observed that night shift work could increase the risk of cancers both in men (OR = 1.14, 95% CI = 1.05--1.25, *P* = 0.003) and women (OR = 1.12, 95% CI = 1.04--1.20, *P* = 0.002), with high heterogeneity in men (*I* ^2^ = 78.3%, *P* ≤ 0.001) and women (*I* ^2^ = 62.3%, *P* ≤ 0.001) ([Figure 2](#fig2){ref-type="fig"}). In cancers that can occur in both men and women (i.e., excluding breast, prostate, and reproductive system cancers, such as ovarian, endometrial, and testis cancer), night shift work demonstrated a positive association with the risk of cancer in men (OR = 1.09, 95% CI = 1.01--1.17, *P* = 0.031) but not in women (OR = 1.02, 95% CI = 0.94--1.12, *P* = 0.637).

3.4. Subgroup Analysis and Metaregression Analysis {#sec3.4}
--------------------------------------------------

To explore the source of potential heterogeneity and assess the influence of specific characteristics of night shift work and cancer risk, we conducted subgroup analyses, including for shift schedule, type of cancer, study region, participant occupation, study design, exposure assessment, number of adjusted variables, and NOS score ([Table 2](#tab2){ref-type="table"}). Among the different work schedules, rotating shift work (OR = 1.14, 95% CI = 1.04--1.24) increased cancer risk whereas fixed shift work (OR = 1.09, 95% CI = 0.90--1.31) did not. A significant relationship was observed for breast cancer (OR = 1.22, 95% CI = 1.08--1.38), prostate cancer (OR = 1.26, 95% CI = 1.05--1.52), and digestive system cancer (OR = 1.15, 95% CI = 1.01--1.32). With respect to region, studies in Europe (OR = 1.18, 95% CI = 1.10--1.28) and North America (OR = 1.16, 95% CI = 1.04--1.31) showed higher ORs than those in Asia and Australia. When stratified by study design, a positive association was revealed for case-control studies (OR = 1.28, 95% CI = 1.15--1.42) and cohort studies (OR = 1.07, 95% CI = 1.00-1.15) but not nested case-control studies. For different occupations, studies based on populations in which no specific occupation was classified showed higher risk estimates (OR = 1.17, 95% CI = 1.10--1.25). Nurses (OR = 1.17, 95% CI = 1.02--1.35) had elevated cancer risk, but participants with industrial occupations did not. The interview group, which had more comprehensive information collection, presented a higher risk estimate (OR = 1.32, 95% CI = 1.17--1.49) than studies using questionnaires and databases to collect information. Regarding NOS score, studies with high-quality scores were associated with increased risk (OR = 1.14, 95% CI = 1.08--1.21) and decreased heterogeneity (*I* ^2^ = 61.6%, *P* ≤ 0.001) whereas those with low-quality scores did not show this positive relationship and had high heterogeneity (*I* ^2^ = 86.9%, *P* ≤ 0.001). Additionally, increased risk was present in studies with more than four adjusted variables. Studies with fewer than four adjusted variables showed no elevated risk of cancer, with high heterogeneity (*I* ^2^ = 82.7%, *P* ≤ 0.001). We performed metaregression analyses to assess the potential heterogeneity sources ([Table 2](#tab2){ref-type="table"}); however, the results showed that none of the subgroups generated the potential heterogeneity.

3.5. Sensitivity Analysis {#sec3.5}
-------------------------

Sensitivity analysis showed that the pooled ORs were stable and did not identify the origins of heterogeneity. After omitting 19 studies by the leave-one-out analyses, we found a stable positive relationship (OR = 1.06, 95% CI = 1.02--1.11) between night shift work and the risk of cancer, with low heterogeneity (*I* ^2^ = 29.8%). It was found that none of the individual studies could powerfully change the positive result.

3.6. Dose--Response Analysis of Night Shift Work and the Risk of Cancers {#sec3.6}
------------------------------------------------------------------------

Twenty-nine studies, which involved at least three levels of night shift exposure, were included in the dose--response analysis of night shift work and cancer risk. We used the two-stage random effects model to evaluate the linearity relationship (*P* \< 0.001). For every 5 years of night shift work, the risk of cancer increased by 3.2% (OR = 1.032, 95% CI = 1.013--1.051) ([Figure 3](#fig3){ref-type="fig"}).

3.7. Publication Bias {#sec3.7}
---------------------

The Begg test showed a potential publication bias among all enrolled studies (*P* = 0.001). After combining the trim and fill method and contour-enhanced funnel plot, the result showed that most of the filled studies were outside the 10% line, which indicated that the previously verified bias was mostly caused by the high heterogeneity, not the publication bias ([Figure 4](#fig4){ref-type="fig"}). The filled risk estimate was still positive, as before (OR = 1.06, 95% CI = 1.01--1.11), such that the pooled OR was stable in our study.

4. Discussion {#sec4}
=============

This meta-analysis, consisting of 58 studies with 225,976 cases and 5,143,838 participants, revealed a positive relationship between night shift work and the risk of cancer. Compared with people who never experience working late, the risk of cancer was found to be increased by 15% in all shift workers, by 12% in female workers and 14% in male workers. A linear dose--response relationship showed a positive gradient of cancer risk with cumulative years of night shift work; for every 5 years of night shift work, cancer risk increased by 3.2%. Yuan et al. \[[@B8]\] confirmed that night shift work elevates the risk of multiple cancers in women, especially breast cancer. Several meta-analyses \[[@B79]--[@B81]\] have verified the positive relationship between night shift work and risk of prostate cancer. We obtained the same result, i.e., that long-time night shift work was associated with a higher risk of breast cancer (OR = 1.22, 95% CI = 1.08--1.38), prostate cancer (OR = 1.26, 95% CI = 1.05--1.52), and cancers in women (OR = 1.12, 95% CI = 1.04--1.20). As far as we know, this is the first meta-analysis to comprehensively explore the effect of night shift work on multiple cancers in the whole population and separately in men and women.

Tissue-specific functions and output circadian rhythms are related to the different cell-based clock genes in periphery \[[@B83]\]. To exclude the tissue-specific influence, we only analyzed cancers that can occur in both men and women and found that night shift work increased cancer risk in men (OR = 1.09, 95% CI = 1.02--1.17) but not in women (OR = 1.02, 95% CI = 0.94--1.12). One meta-analysis involving colorectal cancer \[[@B82]\] demonstrated that night shift work could increase the risk of this type of cancer in women. However, we did not find a risk relationship for either men or women based on more studies of colorectal cancer (data not shown). Although there were considerably fewer articles on other cancers than on breast and prostate cancers, the low heterogeneity for digestive system cancer (*P* = 0.081, *I* ^2^ = 40.2%), hematological system cancer (*P* = 0.066, *I* ^2^ = 54.7%), and lung cancer (*P* = 0.078, *I* ^2^ = 49.5%) presented a more reliable conclusion. Previous studies have suggested that a common mechanism might be shared among hormone-dependent cancers including prostate cancer in men and breast and ovarian cancers in women \[[@B91], [@B92]\]. Melatonin has been implicated in antiproliferation effects in vivo and in vitro, and an elevated PSA level has been strongly connected with night shift work \[[@B91], [@B93]\], which could illustrate why breast and prostate cancers are more sensitive to night shift work than other common cancers.

One meta-analysis \[[@B8]\] analyzing the influence of night shift work on the risk of multiple cancers in women included up to 61 articles. Although light at night (LAN) \[[@B94]\] has been considered one of the risk factors for cancer, studies describing LAN were not included in our meta-analysis if the analysis of LAN was not connected to night shift work. We also excluded cross-sectional studies or studies only describing sleep duration. Therefore, the exposure of all 58 studies in our article was night shift work, which could decrease the clinical heterogeneity, making a more reliable result possible. Whereas the definition of night shift work differs largely among studies, we further divided work schedules into fixed shift, rotating shift, and mixed schedule, to reduce heterogeneity. Consistent with Mancio et al. \[[@B79]\], rotating shift workers had evidence of a higher risk of cancer whereas no association was observed in fixed shift workers. One speculation was that constant and rapid changing work times among rotating shift workers may necessitate a severe circadian disruption, causing failed adaptation, whereas fixed night shift workers had sufficient time to adapt almost completely to the shift cycle \[[@B95]\]. Consequently, rotating shift work resulted in a more profound effect on carcinogenesis through severe circadian disruption.

Our subgroup analyses also uncovered other meaningful results. One finding demonstrated that prostate, breast, and digestive system cancers were connected with night shift work whereas night shift work did not raise the risk of cancers of the hematological system, reproductive system, lung, and skin. In addition, Yuan et al. \[[@B8]\] found that female night shift workers in Europe and North America have greater risk of cancer than women in Asia and Australia. Based on the whole population, our results were consistent with those findings and indicate that the association of cancer risk with night shift work is not largely different between men and women. The different associations might be attributed to the limitations of the study populations. Many studies from Asia were limited to industrial workers whereas most studies from Europe and North America were based on the general population. However, the contrasting results might essentially be owing to differences in ethnicity or sensitivity. More specific exploration based on ethnicity is indispensable in future research. Moreover, studies based on the general population showed a higher cancer risk than those among nurses and industrial workers, and the pooled ORs in population could be better generalized to the overall population. Cohort studies, meaning higher-quality study designs, also indicated the same positive association between night shift work and the risk of cancer. Accordingly, the higher pooled ORs in these subgroups could confirm this association more powerfully.

Through analyzing *Q* and *I* ^2^ values, we found a significant heterogeneity among the studies included in this article (*P* \< 0.001, *I* ^2^ = 76.2%); therefore, we used a random effects model to decrease the heterogeneity. After subgroup analyses, we found that fixed shift work, digestive system cancer, reproductive system cancer, unclassified occupation, interview data collection, and high-quality studies were related to less heterogeneity, representing more reliable results. However, all *P* values in the metaregression analyses did not reflect a statistical difference, such that heterogeneity could not be explained by metaregression analysis. One-by-one-omitted sensitivity and leave-one-out analyses showed that the pooled risk estimates were stable and positive, even when 19 studies were omitted, until heterogeneity was reduced to 29.8%. Although we did not find an obvious source of heterogeneity, the specific subgroup analyses, such as a more uniform definition of work schedules, unclassified occupation based on population, more detailed interviews, and high-quality studies, could decrease the potential heterogeneity.

Theoretical biological mechanisms for the positive relationship between night shift work and cancer risk are complex. First, night shift work and LAN could disturb the normal synchrony with the day--night rhythm and sleeping and diet patterns and bring about circadian disruption, which could suppress the secretion of melatonin \[[@B80]\]. Melatonin plays a pivotal role in inhibiting carcinogenesis through antioxidation, regulation of the immune system, free radical scavenging, and antiangiogenesis \[[@B67]\]. Decreased melatonin levels might disturb its antiproliferation effects on prostate cancer cells both in vivo and in vitro \[[@B93]\] and induce continuous secretion of estrogen, to increase the risk of breast cancer \[[@B77]\]. Second, night shift work can reduce the exposure time to sunlight and subsequently decrease vitamin D levels \[[@B80]\]. Studies have supported the inverse association between circulating vitamin D levels and risk of breast \[[@B96]\], colorectal \[[@B97]\], and prostate cancer \[[@B98]\]. Third, from a molecular perspective, night shift work could constitute a disruption of the feedback loops of circadian genes and lead to subsequent disordered expression of transcription and translation in all cells, which could pose a threat to cell proliferation, metabolism, regulation of the immune system, and DNA damage repair, causing carcinogenesis \[[@B73], [@B74]\].

To the best of our knowledge, this meta-analysis is the first and most comprehensive of its kind to identify the association between night shift work and risk of cancer from the perspective of diverse cancers and by sex. There were several strengths in our meta-analysis. First, we enrolled a large number of articles, even using strict inclusion criteria. The massive study population could enhance statistical power and ensure more accurate risk estimation. Second, a linear dose--response analysis was used to quantify the association between accumulative years of night shift work and cancer risk. Third, we classified work schedules and found that rotating shift work could increase cancer risk whereas fixed shift work could not. The classification of work schedules could decrease clinical heterogeneity to make the results more reliable. Fourth, 34 of 57 studies were carried out among the general population, such that the pooled OR could be better extended to the entire population. Our meta-analysis also had several limitations. First, a significantly high heterogeneity was discovered. We observed significant variability in the study design, risk estimates, study population, definition of night shift work, and exposure assessment. Each of these aspects may generate heterogeneity. Even though many statistical methods were used, we still had trouble finding an obvious source of potential heterogeneity; therefore, the conclusions reached in our meta-analysis should be interpreted with caution. Second, the lack of a consistent definition of night shift work may lead to a certain degree of misclassification and result in a dilution of the pooled OR \[[@B8]\]. Third, given that most night shift workers tend to have lower socioeconomic status, a lower uptake of screening and response rates may result in underestimation of the pooled risk estimates. Finally, studies using interviews could actively collect more detailed information, presenting a stronger risk compared with studies using questionnaire- and database-based data collection. In addition, there is inherent recall bias when conducting interviews or questionnaires. Hence, different exposure assessment methods and studies with lower quality or a less number of adjusted variables can cause information bias.

In conclusion, our meta-analysis identified a positive relationship between night shift work and cancer risk, using a comprehensive perspective of common cancers. We revealed that the risk of cancer increases cumulatively by 3.2% for every 5 years of night shift work. Moreover, we found no difference between men and women in the association between night shift work and the risk of cancer. Overall, on the grounds that public health is adversely affected by night shift work and its prevalence is on the rise, it is indispensable to develop shift work schedules with the aim of reducing cancer risk. Our meta-analysis does not merely increase public awareness, it also supports the recommendation for regular cancer screening among night shift workers.
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Figure S1: forest plots of studies describing the association between night shift work and the risk of multiple cancers. *I* ^2^: the indicator for judging the degree of heterogeneity; OR: odds ratio; CI: confidence interval. The squares and horizontal lines represent the study-specific OR and 95% CI. The diamond represents the pooled OR and 95% CI.

###### 

Click here for additional data file.

![Flow chart of identification of relevant studies.](DM2018-7925219.001){#fig1}

![Forest plots of studies describing the association between night shift work and the risk of multiple cancers in women (a) and men (b) separately. *I* ^2^: the indicator for judging the degree of heterogeneity; OR: odds ratio; CI: confidence interval. The squares and horizontal lines represent the study-specific OR and 95% CI. The diamond represents the pooled OR and 95% CI.](DM2018-7925219.002){#fig2}

![Dose--response relation plots between night shift work and the risk of multiple cancers. OR: odds ratio. Solid line represents the estimated OR by years, and the dotted lines represent the low and upper limits of 95% CIs separately.](DM2018-7925219.003){#fig3}

![The contour-enhanced funnel plot of studies assessing the association between night shift work and the risk of cancers after using the trim and fill method.](DM2018-7925219.004){#fig4}

###### 

Characteristics of studies included in meta-analysis.

  Study (year)                            Region          Study design                No. of cases   Occupation   Exposure                                        Adjusted OR (95% CI)   Type of cancer                 Adjusted item                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Exposure assessment method
  --------------------------------------- --------------- --------------------------- -------------- ------------ ----------------------------------------------- ---------------------- ------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
  Walasa et al. (2018) \[[@B40]\]         Australia       Case-control study          350            NA           Night, never vs. 7.5+ years                     0.95 (0.57--1.58)      Colorectal cancer              Age group, education level, socioeconomic status, lifetime cigarette smoking, and alcohol intake 10 years ago                                                                                                                                                                                                                                                                                                                                                                                   Questionnaire
  Talibov et al. (2018) \[[@B41]\]        Europe          Case-control study          131,594        NA           Rotating, never vs. 20+ years                   1.033 (0.984--1.084)   Hematological system cancer    Cumulative benzene, formaldehyde, and ionizing radiation                                                                                                                                                                                                                                                                                                                                                                                                                                        Questionnaire
  Tse et al. (2017) \[[@B11]\]            Asia            Case-control study          431            NA           Night, never vs. ever                           1.76 (1.07--2.89)      Prostate cancer                Age at interview, marital status, unemployment status, family prostate cancer history, consumption of deep fried food, consumption of pickled vegetable, green tea drinking habits, and cbpai                                                                                                                                                                                                                                                                                                   Interview
  Heckman et al. (2017) \[[@B44]\]        North America   Cohort study                4854           Nurses       Rotating, never vs. 10+ years                   0.794 (0.711--0.888)   Skin cancer                    Years of shift work, hours of sleep, sleep adequacy, sleepy days per week, snoring, restless legs syndrome, family history of melanoma, hours spent in sun, number of severe sunburns, sunburn severity, artificial tanning frequency, annual uv at residence, moles on lower legs, natural hair color in adolescence, marital status, financial status, BMI, physical activity, smoking status, menopausal status, postmenopausal hormones, oral contraceptive use, and healthy eating index   Questionnaire
  Papantoniou (2017) \[[@B12]\]           Europe          Case-control study          1626           NA           Night and rotating, never vs. 15+ years         1.28 (1.06--1.56)      Colorectal cancer              Age, centre, educational level, sex, history of colorectal cancer, BMI, smoking, leisure time physical activity, alcohol consumption, total energy intake in grams/day, all red meat consumption, sleep duration, bisphosphonates, and NSAIDs                                                                                                                                                                                                                                                   Questionnaire
  Devore et al. (2017) \[[@B45]\]         North America   Cohort study                3014           Nurses       Rotating, never vs. 10+ years                   0.96 (0.83, 1.11)      Colorectal adenoma             Age, time period of first lower endoscopy, reason for endoscopy, family history of cancer, height, BMI, physical activity, smoking, alcohol intake, menopausal status, menopausal hormone use, oral contraceptive use, multivitamin use, total calcium intake, vitamin d intake, red meat intake, NSAIDs use, and predicted vitamin D score                                                                                                                                                     Questionnaire
  Vistisen et al. (2017) \[[@B42]\]       Europe          Cohort study                1245           NA           Night, never vs. ever                           0.90 (0.80--1.01)      Breast cancer                  Calendar year, age, age at birth of first child, number of births, family history of breast cancer or ovarian cancer, oral contraception, hormone replacement therapy, other sex hormones, medication related to alcoholism, mammography screening attendance, and highest family educational level                                                                                                                                                                                             Database
  Wegrzyn et al. (2017)^a^ \[[@B10]\]     North America   Cohort study                5971           Nurses       Rotating, never vs. 30+ years                   0.95 (0.77--1.17)      Breast cancer                  Age, height, BMI, BMI at age 18, adolescent body size, age at menarche, age at first birth and parity combined, breast feeding, type of menopause and age at menopause, combined menopausal hormone therapy, duration of estrogen alone menopausal hormone therapy, duration of estrogen and progesterone menopausal hormone therapy, first-degree family history of breast cancer, history of benign breast disease, alcohol consumption, physical activity, and current mammography use.      Questionnaire
  Wegrzyn et al. (2017)^a^ \[[@B10]\]     North America   Cohort study                3570           Nurses       Rotating, never vs. 20+ years                   2.15 (1.23--3.73)      Breast cancer                  Age, height, BMI, BMI at age 18, adolescent body size, age at menarche, age at first birth and parity combined, breast feeding, type of menopause and age at menopause, combined menopausal hormone therapy, duration of estrogen alone menopausal hormone therapy, duration of estrogen and progesterone menopausal hormone therapy, first-degree family history of breast cancer, history of benign breast disease, alcohol consumption, physical activity, and mammography use.              Questionnaire
  Jørgensen et al. (2017) \[[@B43]\]      Europe          Cohort study                945            Nurses       Rotating, night, and rotating, never vs. ever   0.91 (0.77--1.08)      Unclassified cancer            Age, smoking, pack-years, physical activity, BMI, alcohol consumption, diet (vegetables, fruit, and fatty meat consumption), preexisting diseases (hypertension, diabetes, and myocardial infarction), self-reported health, stressful work environment, marital status, female reproductive factors (birth, use of hormone therapy, and oral contraceptives)                                                                                                                                   Questionnaire
  Behrens et al. (2017) \[[@B13]\]        Europe          Cohort study                76             NA           Rotating, never vs. 20+ years                   3.08 (1.67--5.69)      Prostate cancer                Age, smoking, family history of prostate cancer, level of school education, and equivalent income                                                                                                                                                                                                                                                                                                                                                                                               Interview
  Akerstedt et al. (2017) \[[@B46]\]      Europe          Cohort study                454            NA           Night, never vs. ever                           0.91 (0.74--1.12)      Prostate cancer                Age, education level, tobacco consumption, BMI, having children, coffee consumption, and previous cancer                                                                                                                                                                                                                                                                                                                                                                                        Interview
  Dickerman et al. (2016) \[[@B49]\]      Europe          Cohort study                602            NA           Rotating, never vs. ever                        1.0 (0.7--1.2)         Prostate cancer                Age, education, BMI, physical activity, social class, smoking status, alcohol use, snoring, and zygosity                                                                                                                                                                                                                                                                                                                                                                                        Questionnaire
  Papantoniou et al. (2016) \[[@B47]\]    Europe          Case-control study          1708           NA           Night and rotating, never vs. 15+ years         1.21 (0.89--1.65)      Breast cancer                  Age, centre, educational level, parity, menopausal status, family history of breast cancer, BMI, smoking status, oral contraceptive use, leisure time physical activity, alcohol consumption, and sleep duration                                                                                                                                                                                                                                                                                Interview
  Gyarmati et al. (2016) \[[@B48]\]       Europe          Case-control study          374            NA           Night and rotating, never vs. 20+ years         1.1 (0.8--1.6)         Stomach cancer                 Age, sex, educational level, centre, BMI, cigarette smoking status, family history, physical activity level, total energy intake, grams of red meat, grams of vegetables, and grams of fruit and alcohol consumption                                                                                                                                                                                                                                                                            Interview
  Costas et al. (2016) \[[@B15]\]         Europe          Case-control study          321            NA           Night, never vs. 20+ years                      1.77 (1.14--2.74)      Chronic lymphocytic leukemia   Region, age, sex, worked on a farm, family history of hematologic malignancies, BMI, tobacco consumption (never, past, and current), sleep problems, and education                                                                                                                                                                                                                                                                                                                              Interview
  Bai et al. (2016) \[[@B16]\]            Asia            Cohort study                1251           NA           Night, never vs. 20+ years                      1.08 (0.90--1.29)      Unclassified cancer            Age, BMI, family history of cancer, alcohol drinking and smoking status, number of children, menopausal status, hormone replacement therapy, and contraception status                                                                                                                                                                                                                                                                                                                           Questionnaire
  Travis et al. (2016) \[[@B14]\]         Europe          Cohort study                4809           NA           Night, never vs. ever                           1.00 (0.92--1.08)      Breast cancer                  Socioeconomic status, parity and age at first birth, BMI, alcohol intake, strenuous physical activity, family history of breast cancer, age at menarche, oral contraceptive use, smoking, living with a partner, and hormone therapy                                                                                                                                                                                                                                                            Questionnaire
  Gu et al. (2015) \[[@B20]\]             North America   Cohort study                5413           Nurses       Rotating, never vs. 15+ years                   1.08 (0.98--1.19)      Unclassified cancer            Age, alcohol consumption, physical exercise, multivitamin use, menopausal status and postmenopausal hormone use, physical exam in the past 2 years, healthy eating score, smoking status, pack-years, BMI, and husband\'s education                                                                                                                                                                                                                                                             Questionnaire
  Wang P. et al. (2015) \[[@B17]\]        Asia            Case-control study          712            NA           Night, never vs. ever                           1.34 (1.05--1.72)      Breast cancer                  Age, education, BMI, age at menarche, menopausal status, parity, physical activity, breast feeding, and family history of cancer                                                                                                                                                                                                                                                                                                                                                                Interview
  Papantoniou et al. (2015) \[[@B18]\]    Europe          Case-control study          1115           NA           Night and rotating, never vs. 28+ years         1.38 (1.05--1.81)      Prostate cancer                Age, centre, educational level, family history of prostate cancer, physical activity over the past decade, smoking status, past sun exposure, and daily meat consumption                                                                                                                                                                                                                                                                                                                        Interview
  Li et al. (2015) \[[@B51]\]             Asia            Nested case-control study   1709           Industry     Night, never vs. ever                           0.73 (0.66--0.82)      Breast cancer                  Age at the beginning of follow-up                                                                                                                                                                                                                                                                                                                                                                                                                                                               Questionnaire
  Lin et al. (2015) \[[@B50]\]            Asia            Cohort study                94             NA           Rotating, never vs. ever                        1.43 (0.78--2.63)      Biliary tract cancer           Age, BMI, history of cholelithiasis, history of diabetes, cigarette smoking, alcohol drinking, perceived stress, and sleep time                                                                                                                                                                                                                                                                                                                                                                 Questionnaire
  Kwon et al. (2015) \[[@B52]\]           Asia            Nested case-control study   1451           Industry     Rotating, never vs. 30.6+ years                 0.88 (0.69--1.12)      Lung cancer                    Adjusted for age, smoking, parity, and endotoxin                                                                                                                                                                                                                                                                                                                                                                                                                                                Database
  Akerstedt et al. (2015) \[[@B21]\]      Europe          Cohort study                463            NA           Night, never vs. 21+ years                      1.77 (1.03--3.04)      Breast cancer                  Age, education level, tobacco consumption, BMI, having children, coffee consumption, previous cancer, and use of hormones including oral contraceptives                                                                                                                                                                                                                                                                                                                                         Interview
  Hammer et al. (2015) \[[@B19]\]         Europe          Cohort study                337            Industry     Rotating, never vs. ever                        0.93 (0.73--1.18)      Prostate cancer                Age and professional status                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Database
  Gapstur et al. (2014) \[[@B55]\]        North America   Cohort study                4974           NA           Rotating, night, and evening, never vs. ever    1.08 (0.95--1.22)      Prostate cancer                Age, race, education, BMI, smoking status, family history of prostate cancer, and painful/frequent urination                                                                                                                                                                                                                                                                                                                                                                                    Questionnaire
  Koppes et al. (2014) \[[@B54]\]         Australia       Cohort study                2531           NA           Night, never vs. ever                           0.87 (0.72--1.05)      Breast cancer                  Night work, age, origin, children in household, education, occupation, job tenure (years), and contractual working hours                                                                                                                                                                                                                                                                                                                                                                        Interview
  Carter et al. (2014) \[[@B23]\]         North America   Cohort study                1289           NA           Rotating, night, and evening, never vs. ever    1.27 (1.03--1.56)      Ovarian cancer                 Oral contraceptive use, age at menarche and menopause, tubal ligation, parity, postmenopausal estrogen use, race, family history of cancers, exercise, BMI, and height                                                                                                                                                                                                                                                                                                                          Questionnaire
  Yong et al. (2014) \[[@B53]\]           Europe          Cohort study                10,873         Industry     Rotating, never vs. ever                        1.04 (0.89--1.21)      Unclassified cancer            Age, job level, cigarette smoking, and employment duration in categories                                                                                                                                                                                                                                                                                                                                                                                                                        Questionnaire
  Datta et al. (2014) \[[@B56]\]          Asia            Case-control study          50             Industry     Night, never vs. ever                           1.51 (0.27--8.52)      Breast cancer                  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Interview
  Truong et al. (2014) \[[@B22]\]         Europe          Case-control study          1126           NA           Night, never vs. ever                           1.32 (1.02--1.72)      Breast cancer                  Age, study area, parity, age at first full-term pregnancy, age at menarche, family history of breast cancer, current use of hormonal replacement therapy, BMI, tobacco, and alcohol                                                                                                                                                                                                                                                                                                             Interview
  Knutsson et al. (2013) \[[@B26]\]       Europe          Cohort study                94             NA           Night, never vs. ever                           2.02 (1.03--3.95)      Breast cancer                  Height, weight, waist, hip circumference, educational level, number of children, smoking, menopausal status, oral contraceptive use, hormones other than contraceptives, alcohol intake, educational level, BMI, and waist--hip ratio                                                                                                                                                                                                                                                           Questionnaire
  Rabstein et al. (2013) \[[@B57]\]       Europe          Case-control study          857            NA           Night, never vs. ever                           1.01 (0.68--1.5)       Breast cancer                  Age, adjusted for family history of breast cancer, hormone replacement use, and number of mammograms                                                                                                                                                                                                                                                                                                                                                                                            Interview
  Fritschi et al. (2013) \[[@B59]\]       Australia       Case-control study          1205           NA           Night, never vs. 20+ years                      1.02 (0.71--1.45)      Breast cancer                  Light at night, phase shift and sleep disruption, poor diet, lack of physical activity and little time outdoors, and age                                                                                                                                                                                                                                                                                                                                                                        Questionnaire
  Schernhammer et al. (2013) \[[@B24]\]   North America   Cohort study                1455           Nurses       Rotating, never vs. 15+ years                   1.28 (1.07--1.53)      Lung cancer                    Age, smoking status, age at start of smoking, cigarettes smoked per day among current smoker, time since quitting among past smokers, fruit intake, vegetable intake, BMI, and environmental smoking exposures                                                                                                                                                                                                                                                                                  Questionnaire
  Menegaux et al. (2013) \[[@B25]\]       Europe          Case-control study          1232           NA           Night, never vs. 4.5+ years                     1.40 (1.01--1.92)      Breast cancer                  Age, study area, parity, age at first full-term pregnancy, age at menarche, family history of breast cancer, current hormonal replacement therapy, BMI, tobacco, and alcohol                                                                                                                                                                                                                                                                                                                    Interview
  Grundy et al. (2013) \[[@B27]\]         North America   Case-control study          1134           NA           Mixed, never vs. 30+ years                      2.21 (1.14--4.31)      Breast cancer                  Age and centre                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Questionnaire
  Bhatti et al. (2013) \[[@B60]\]         North America   Case-control study          1490           NA           Night, never vs. 7+ years                       1.02 (0.74--1.42)      Ovarian cancer                 Age at reference, county, reference year, duration of oral contraceptive use, number of full-term pregnancies, and BMI                                                                                                                                                                                                                                                                                                                                                                          Interview
  Lin et al. (2013) \[[@B58]\]            Asia            Cohort study                127            Industry     Rotating, never vs. ever                        0.83 (0.43--1.60)      Pancreatic cancer              Age, BMI, history of diabetes, alcohol drinking, cigarette smoking, perceived stress, and sleep time                                                                                                                                                                                                                                                                                                                                                                                            Questionnaire
  Hansen and Stevens (2012) \[[@B30]\]    Europe          Nested case-control study   267            Nurses       Night and evening, never vs. 20+ years          2.1 (1.3--3.2)         Breast cancer                  Adjusted for age, weight regularity, use of hormone replacement therapy, age at menarche, menstrual regularity, menopausal status, age at birth of first child, breast cancer in mother or sister, and total duration of lactation                                                                                                                                                                                                                                                              Interview
  Hansen and Lassen (2012) \[[@B31]\]     Europe          Nested case-control study   132            Industry     Evening, never vs. 15+ years                    2.1 (1.0--4.5)         Breast cancer                  Adjusted for age, hormone replacement therapy, number of childbirths, age at menarche, years of education, occasional sunbathing frequency, and tobacco smoking status                                                                                                                                                                                                                                                                                                                          Questionnaire
  Parent et al. (2012) \[[@B28]\]         North America   Case-control study          3137           NA           Night, never vs. 10+ years                      2.016 (1.246--3.261)   Unclassified cancer            None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Interview
  Natti et al. (2012) \[[@B29]\]          Europe          Cohort study                99             NA           Night, never vs. ever                           2.148 (1.178--3.917)   Unclassified cancer            Age, longstanding illness (among men), and smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                       Interview
  Kubo et al. (2011) \[[@B32]\]           Asia            Cohort study                17             Industry     Rotating, never vs. ever                        1.79 (0.57--5.68)      Prostate cancer                Age, BMI, alcohol intake, smoking, exercise, and marital status                                                                                                                                                                                                                                                                                                                                                                                                                                 Database
  Lie et al. (2011) \[[@B62]\]            Europe          Nested case-control study   699            Nurses       Night, never vs. 12+ years                      1.3 (0.9--1.8)         Breast cancer                  Age, period of diagnosis, parity, family history of breast cancer in mother or sister, and frequency of alcohol consumption at time of diagnosis                                                                                                                                                                                                                                                                                                                                                Interview
  Poole et al. (2011) \[[@B61]\]          North America   Cohort study                718            Nurses       Rotating, never vs. 20+ years                   0.8 (0.51--1.23)       Ovarian cancer                 Age, duration of oral contraceptive use, parity, BMI, smoking status, tubal ligation history, menopausal status, family history of ovarian cancer (yes/no), and duration of breastfeeding                                                                                                                                                                                                                                                                                                       Questionnaire
  Pesch et al. (2010) \[[@B64]\]          Europe          Case-control study          753            NA           Night, never vs. 20+ years                      2.48 (0.62--9.99)      Breast cancer                  Age in 5-year groups, adjusted for family history of breast cancer, hormone replacement use, and number of mammograms                                                                                                                                                                                                                                                                                                                                                                           Interview
  Pronk et al. (2010) \[[@B63]\]          Asia            Cohort study                349            NA           Mixed, never vs. 17+ years                      0.8 (0.5--1.2)         Breast cancer                  Age, education, family history of breast cancer, number of pregnancies, age at first birth, and physical activity                                                                                                                                                                                                                                                                                                                                                                               Interview
  Lahti et al. (2008) \[[@B33]\]          Europe          Cohort study                6307           NA           Rotating, never vs. ever                        1.07 (1.01--1.13)      Non-Hodgkin lymphoma           Age, social class, and cohort period                                                                                                                                                                                                                                                                                                                                                                                                                                                            Database
  Viswanathan et al. (2007) \[[@B34]\]    North America   Cohort study                515            Nurses       Rotating, never vs. 20+ years                   1.47 (1.03--2.10)      Endometrial cancer             Age, age at menarche, age at menopause, parity, BMI, oral contraceptive use, use and duration of postmenopausal hormones, hypertension, diabetes, and smoking                                                                                                                                                                                                                                                                                                                                   Questionnaire
  Lie et al. (2006) \[[@B36]\]            Europe          Nested case-control study   537            Nurses       Rotating, never vs. 30+ years                   2.21 (1.10--4.45)      Breast cancer                  Total employment time as a nurse and parity                                                                                                                                                                                                                                                                                                                                                                                                                                                     Database
  O\'Leary et al. (2006) \[[@B65]\]       North America   Case-control study          487            NA           Mixed, never vs. ever                           1.04 (0.79--1.38)      Breast cancer                  Age at reference date, parity, family history, education, and history of benign breast disease                                                                                                                                                                                                                                                                                                                                                                                                  Interview
  Schernhammer et al. (2006) \[[@B35]\]   North America   Cohort study                1352           Nurses       Rotating, never vs. 20+ years                   1.79 (1.06--3.01)      Breast cancer                  Age, age at menarche, menopausal status, age at menopause, age at first birth, BMI, current alcohol consumption, oral contraceptive use, postmenopausal hormone use, smoking status, benign breast disease, family history of breast cancer, and physical activity                                                                                                                                                                                                                              Questionnaire
  Kubo et al. (2006) \[[@B37]\]           Asia            Cohort study                31             Industry     Rotating, never vs. ever                        3.0 (1.2--7.7)         Prostate cancer                Age, study area, family history of prostate cancer, BMI, smoking, alcohol drinking, job type, physical activity at work, workplace, perceived stress, educational level, and marriage status                                                                                                                                                                                                                                                                                                    Questionnaire
  Schernhammer et al. (2003) \[[@B38]\]   North America   Cohort study                602            Nurses       Rotating, never vs. 15+ years                   1.35 (1.03--1.77)      Colorectal cancer              Age in years, smoking, BMI, physical activity in quintiles, regular aspirin use, colorectal cancer in parent or sibling, screening endoscopy during the study period, consumption of beef, pork, or lamb as a main dish, alcohol consumption status, total caloric intake in quintiles, use of postmenopausal hormones, menopausal status, and height in seven categories                                                                                                                       Questionnaire
  Davis et al. (2001) \[[@B66]\]          North America   Case-control study          767            NA           Mixed, never vs. 3+ years                       1.6 (0.8--3.2)         Breast cancer                  Parity, family history of breast cancer (mother or sister), oral contraceptive use (ever), and recent (\<5 years) discontinued use of hormone replacement therapy                                                                                                                                                                                                                                                                                                                               Interview
  Hansen (2001) \[[@B39]\]                Europe          Case-control study          6281           NA           Night, never vs. 0.6+ years                     1.5 (1.3--1.7)         Breast cancer                  Age, social class, age at birth of first child, age at birth of last child, and number of children                                                                                                                                                                                                                                                                                                                                                                                              Interview

Abbreviations: BMI: body mass index; NSAIDs: nonsteroidal anti-inflammatory drugs; NA: not available. ^a^This study included two prospective cohorts (NHS and NHS2).

###### 

The results of subgroup analyses and metaregression analyses on the association between night shift work and the risk of cancers.

  Subgroup                       No. of studies   Weight (%)   OR (95% CI)         *I* ^2^   *P* for heterogeneity   *P* ^∗^ for interaction
  ------------------------------ ---------------- ------------ ------------------- --------- ----------------------- -------------------------
  Shift schedule^a^                                                                                                  0.570
   Rotating shift                29               46.97        1.14 (1.04--1.24)   68.7%     \<0.001                 
   Fixed shift                   9                11.19        1.09 (0.90--1.31)   51.1%     0.037                   
   Mixed shift                   27               41.84        1.20 (0.82--1.77)   80.7%     \<0.001                 
  Type of cancer^b^                                                                                                  0.298
   Digestive system cancer       11               15.72        1.15 (1.01--1.32)   40.2%     0.081                   
   Hematological system cancer   5                9.12         1.08 (0.99--1.17)   54.7%     0.066                   
   Prostate cancer               11               16.10        1.26 (1.05--1.52)   73.2%     \<0.001                 
   Breast cancer                 37               39.62        1.22 (1.08--1.38)   81.2%     \<0.001                 
   Reproductive system cancer    6                7.99         1.06 (0.85--1.32)   49.5%     0.078                   
   Lung cancer                   5                7.53         1.08 (0.87--1.35)   53.4%     0.073                   
   Skin cancer                   3                3.92         0.93 (0.50--1.74)   74.9%     0.019                   
  Region                                                                                                             0.298
   Australia                     3                5.03         0.91 (0.77--1.06)   0.0%      0.728                   
   Europe                        27               48.92        1.18 (1.10--1.28)   75.1%     \<0.001                 
   Asia                          11               14.29        1.11 (0.88--1.39)   78.3%     \<0.001                 
   North America                 17               31.75        1.16 (1.04--1.31)   76.1%     \<0.001                 
  Occupation                                                                                                         0.795
   Unclassified occupation       35               61.45        1.17 (1.10--1.25)   69.7%     \<0.001                 
   Industry                      9                12.09        1.00 (0.81--1.24)   72.8%     \<0.001                 
   Nurses                        14               26.46        1.17 (1.02--1.35)   80.6%     \<0.001                 
  Study design                                                                                                       0.845
   Case-control study            21               32.23        1.28 (1.15--1.42)   66.5%     \<0.001                 
   Nested case-control study     6                9.08         1.30 (0.89--1.90)   88.0%     \<0.001                 
   Cohort study                  31               58.69        1.07 (1.00--1.15)   70.9%     \<0.001                 
  Exposure assessment                                                                                                0.075
   Questionnaire                 28               53.99        1.08 (1.00--1.17)   77.1%     \<0.001                 
   Interview                     24               34.52        1.32 (1.17--1.49)   66.3%     \<0.001                 
   Database                      6                9.06         1.00 (0.85--1.18)   77.1%     0.004                   
  Number of adjusted variables                                                                                       0.926
   ≤4                            15               22.84        1.13 (0.99--1.28)   82.7%     \<0.001                 
   \>4                           43               77.16        1.16 (1.08--1.24)   72.8%     \<0.001                 
  Study score                                                                                                        0.585
   Low quality                   17               25.20        1.16 (0.98--1.37)   86.9%     \<0.001                 
   High quality                  41               74.80        1.14 (1.08--1.21)   61.6%     \<0.001                 

^a,b^Five studies report their studies including different kinds of cancer; nine articles report their studies including different types of shift schedules. ^∗^ *P* values for metaregression.

[^1]: Academic Editor: Fabrizia Bamonti
